Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 267808, 10 pages
http://dx.doi.org/10.1155/2014/267808
Research Article

The Role of Neurotrophic Factors Conjugated to Iron Oxide Nanoparticles in Peripheral Nerve Regeneration: In Vitro Studies

1NVR Research Ltd., Heharash Street 11, 74031 Ness-Ziona, Israel
2Institute of Nanotechnology and Advanced Materials, Department of Chemistry, Bar-Ilan University, 52900 Ramat-Gan, Israel
3Department of Clinical and Biological Sciences, Università degli studi di Torino, Regione Gonzole 10, 10043 Orbassano, Italy
4Institute of Neuroanatomy, Hannover Medical School, Carl-Neuberg-Street 1, 30623 Hannover, Germany
5Center for Systems Neuroscience (ZSN) Hannover, 30559 Hannover, Germany

Received 9 February 2014; Accepted 17 June 2014; Published 16 July 2014

Academic Editor: Fausto Viterbo

Copyright © 2014 Ofra Ziv-Polat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Lundborg, “Alternatives to autologous nerve grafts,” Handchirurgie, Mikrochirurgie, Plastische Chirurgie, vol. 36, no. 1, pp. 1–7, 2004. View at Google Scholar
  2. C. Grothe, K. Haastert-Talini, T. Freier et al., “BIOHYBRID-Biohybrid templates for peripheral nerve regeneration,” Journal of the Peripheral Nervous System, vol. 17, no. 2, pp. 220–222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. Y.-C. Huang and Y.-Y. Huang, “Tissue engineering for nerve repair,” Biomedical Engineering: Applications, Basis and Communications, vol. 18, pp. 100–110, 2006. View at Google Scholar
  4. S. M. Willerth and S. E. Sakiyama-Elbert, “Approaches to neural tissue engineering using scaffolds for drug delivery,” Advanced Drug Delivery Reviews, vol. 59, no. 4-5, pp. 325–338, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. S. Straley, C. W. P. Foo, and S. C. Heilshorn, “Biomaterial design strategies for the treatment of spinal cord injuries,” Journal of Neurotrauma, vol. 27, no. 1, pp. 1–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Lu and M. H. Tuszynski, “Growth factors and combinatorial therapies for CNS regeneration,” Experimental Neurology, vol. 209, no. 2, pp. 313–320, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Aloe, “Rita Levi-Montalcini: the discovery of nerve growth factor and modern neurobiology,” Trends in Cell Biology, vol. 14, no. 7, pp. 395–399, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Varon, J. Nomura, and E. M. Shooter, “Reversible dissociation of the mouse nerve growth factor protein into different subunits,” Biochemistry, vol. 7, no. 4, pp. 1296–1303, 1968. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Sun, C. Sun, H. Lin et al., “The effect of collagen-binding NGF-β on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model,” Biomaterials, vol. 30, no. 27, pp. 4649–4656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Höke, T. Ho, T. O. Crawford, C. LeBel, D. Hilt, and J. W. Griffin, “Glial cell line-derived neurotrophic factor alters axon Schwann cell units and promotes myelination in unmyelinated nerve fibers,” The Journal of Neuroscience, vol. 23, no. 2, pp. 561–567, 2003. View at Google Scholar · View at Scopus
  11. L. Zhang, Z. Ma, G. M. Smith et al., “GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons,” GLIA, vol. 57, no. 11, pp. 1178–1191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. K. D. Beck, J. Valverde, T. Alexi et al., “Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain,” Nature, vol. 373, no. 6512, pp. 339–341, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. S. B. Rangasamy, K. Soderstrom, R. A. E. Bakay, and J. H. Kordower, “Neurotrophic factor therapy for Parkinson's disease,” Progress in Brain Research, vol. 184, pp. 237–264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. S. Morrison, A. Sharma, J. de Vellis, and R. A. Bradshaw, “Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 19, pp. 7537–7541, 1986. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin, “Biological roles of fibroblast growth factor-2,” Endocrine Reviews, vol. 18, no. 1, pp. 26–45, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Grothe and G. Nikkhah, “The role of basic fibroblast growth factor in peripheral nerve regeneration,” Anatomy and Embryology, vol. 204, no. 3, pp. 171–177, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Allodi, L. Casals-Díaz, E. Santos-Nogueira, F. Gonzalez-Perez, X. Navarro, and E. Udina, “FGF-2 low molecular weight selectively promotes neuritogenesis of motor neurons in vitro,” Molecular Neurobiology, vol. 47, no. 2, pp. 770–781, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Haastert, E. Lipokatić, M. Fischer, M. Timmer, and C. Grothe, “Differentially promoted peripheral nerve regeneration by grafted Schwann cells over-expressing different FGF-2 isoforms,” Neurobiology of Disease, vol. 21, no. 1, pp. 138–153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Grothe, K. Haastert, and J. Jungnickel, “Physiological function and putative therapeutic impact of the FGF-2 system in peripheral nerve regeneration—lessons from in vivo studies in mice and rats,” Brain Research Reviews, vol. 51, no. 2, pp. 293–299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Knusel, P. P. Michel, J. S. Schwaber, and F. Hefti, “Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II,” Journal of Neuroscience, vol. 10, no. 2, pp. 558–570, 1990. View at Google Scholar · View at Scopus
  21. H. Skaat, O. Ziv-Polat, A. Shahar, and S. Margel, “Enhancement of the growth and differentiation of nasal olfactory mucosa cells by the conjugation of growth factors to functional nanoparticles,” Bioconjugate Chemistry, vol. 22, no. 12, pp. 2600–2610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Ziv-Polat, H. Skaat, A. Shahar, and S. Margel, “Novel magnetic fibrin hydrogel scaffolds containing thrombin and growth factors conjugated iron oxide nanoparticles for tissue engineering,” International Journal of Nanomedicine, vol. 7, no. 1, pp. 1259–1274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Schubert, “Synergistic interactions between transforming growth factor beta and fibroblast growth factor regulate Schwann cell mitosis,” Journal of Neurobiology, vol. 23, no. 2, pp. 143–148, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Zhang and H. Uludaǧ, “Nanoparticulate systems for growth factor delivery,” Pharmaceutical Research, vol. 26, no. 7, pp. 1561–1580, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. E. R. Edelman, M. A. Nugent, and M. J. Karnovsky, “Perivascular and intravenous administration of basic fibroblast growth factor: Vascular and solid organ deposition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 4, pp. 1513–1517, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. G. F. Whalen, Y. Shing, and J. Folkman, “The fate of intravenously administered bFGF and the effect of heparin,” Growth Factors, vol. 1, no. 2, pp. 157–164, 1989. View at Google Scholar · View at Scopus
  27. T. Sakane and W. M. Pardridge, “Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity,” Pharmaceutical Research, vol. 14, no. 8, pp. 1085–1091, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. D. N. Ishii and E. M. Shooter, “Regulation of nerve growth factor synthesis in mouse submaxillary glands by testosterone,” Journal of Neurochemistry, vol. 25, no. 6, pp. 843–851, 1975. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Pradier, I. Jalenques, M. Dalle, R. Reuling, G. Despres, and R. Romand, “Distribution and metabolism patterns of plasma 7S- and β-NGF in the adult male rat,” Journal of Physiology Paris, vol. 88, no. 5, pp. 273–277, 1994. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Lee, E. A. Silva, and D. J. Mooney, “Growth factor delivery-based tissue engineering: general approaches and a review of recent developments,” Journal of the Royal Society Interface, vol. 8, no. 55, pp. 153–170, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. C. Berry and A. S. G. Curtis, “Functionalisation of magnetic nanoparticles for applications in biomedicine,” Journal of Physics D Applied Physics, vol. 36, no. 13, pp. R198–R206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Shahar, Z. Nevo, and S. Rochkind, “Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants,” US Patent 0024373, 2001.
  33. S. Margel, O. Ziv-Polat, H. Skaat, A. Shahar, and Assignee Bar-Ilan University, “Novel nanocomposite gel and fibrin scaffold for cell implantation and tissue engineering,” Provisional US Patent Application no. 61457989 (7/2011), 61678109 (8/2012), 2012.
  34. R. S. Molday and D. Mackenzie, “Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells,” Journal of Immunological Methods, vol. 52, no. 3, pp. 353–367, 1982. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Skaat, O. Ziv-Polat, A. Shahar, and S. Margel, “Enhanced cell growth by new magnetic scaffolds containing bioactive-conjugated nanoparticles for tissue engineering,” in Applications of Nanomaterials, J. N. Govil, Ed., Studium Press LLC, Houston, Tex, USA, 2012. View at Google Scholar
  36. T. Green-Sadan, Y. Kuttner, T. Lublin-Tennenbaum et al., “Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats,” Experimental Neurology, vol. 194, no. 1, pp. 97–105, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. O. Ziv-Polat, M. Topaz, T. Brosh, and S. Margel, “Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles,” Biomaterials, vol. 31, no. 4, pp. 741–747, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Shafir, A. Galperin, and S. Margel, “Synthesis and characterization of recombinant factor VIIa-conjugated magnetic iron oxide nanoparticles for hemophilia treatment,” Journal of Biomedical Materials Research A, vol. 91, no. 4, pp. 1056–1064, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Corem-Salkmon, Z. Ram, D. Daniels et al., “Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles,” International Journal of Nanomedicine, vol. 6, pp. 1595–1602, 2011. View at Google Scholar · View at Scopus
  40. S. Rochklnd, D. El-Ani, Z. Nevo, and A. Shahar, “Increase of neuronal sprouting and migration using 780 nm laser phototherapy as procedure for cell therapy,” Lasers in Surgery and Medicine, vol. 41, no. 4, pp. 277–281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Rochkind, A. Shahar, D. Fliss et al., “Development of a tissue-engineered composite implant for treating traumatic paraplegia in rats,” European Spine Journal, vol. 15, no. 2, pp. 234–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Rochkind, L. Astachov, D. El-Ani et al., “Further development of reconstructive and cell tissue-engineering technology for treatment of complete peripheral nerve injury in rats,” Neurological Research, vol. 26, no. 2, pp. 161–166, 2004. View at Publisher · View at Google Scholar · View at Scopus